HARTFORD — Connecticut is poised to make a new class of costly hepatitis C drugs more accessible to the state's poorest patients.
state Department of Social Services will classify Sovaldi, Harvoni and
Viekira Pak as preferred drugs in its Medicaid program, which means they
will be "readily available to our clients,'' said department spokesman
The department is also simplifying its
prior authorization process, which had been criticized by advocates for
hepatitis C patients as a tactic designed to limit access to the
expensive but highly effective treatments.
Labels: Connecticut, medicaid, streamlining access